Belgium
Jul 17, 2008
Boehringer Ingelheim licenses drug targets from autoimmune collaboration with Galapagos
Mechelen, Belgium; 17 July 2008 - Galapagos NV announced today that Boehringer Ingelheim has exercised its right to license two drug targets from the autoimmune research agreement with Galapagos' BioFocus DPI ...
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| SRO and Business permit | Wed | Nina | 1 |
| Hi, How's Belgium...? (from Jan '06) | Oct 12 | RATM | 135 |
| During economic crisis, it's every nation for i... | Oct 10 | Rodann | 10 |
| 478-carat diamond found in Africa | Oct 7 | isa | 4 |
| Lesotho mine yields 478-carat diamond | Oct 5 | KHUBELU | 9 |
| European leaders urge US to act | Sep 30 | John M | 4 |
| Looking for Boreman a former Belgian pilot | Sep 30 | M Decastiau | 1 |
Aquarius
Most Popular